MedTrace Logo

Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma

NCT04623658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2026-03-09

No results posted yet for this study

Summary

Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. However, predicting factors of evolution, sequelae and relapse are still unreliable because of small-cohort studies. This study aims at identifying prenatal and postnatal prognostic factors of evolution of SCT during pregnancy, of postnatal relapse, and of medium and long-term sequelae (urinary, digestive, esthetic, psychologic) in order to improve parental counseling when the diagnosis of SCT is made during pregnancy.

Conditions

  • Sacrococcygeal Teratoma

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Sabine Sarnacki, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Nicolas Vinit, Resident, MSc · Assistance Publique - Hôpitaux de Paris

Eligibility

Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04623658 on ClinicalTrials.gov